Meta-Analysis of Randomized Trials of Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus

Diabetes mellitus is a major risk factor for restenosis in patients undergoing percutaneous coronary intervention. Randomized controlled trials comparing drug-eluting stents (DESs) with bare metal stents (BMSs) showed a marked decrease in in-stent restenosis and target lesion revascularization with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2007-05, Vol.99 (10), p.1399-1402
Hauptverfasser:	Boyden, Thomas F., MD, Nallamothu, Brahmajee K., MD, MPH, Moscucci, Mauro, MD, Chan, Paul S., MD, MSc, Grossman, P. Michael, MD, Tsai, Thomas T., MD, Chetcuti, Stanley J., MD, Bates, Eric R., MD, Gurm, Hitinder S., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty, Balloon, Coronary Blood Vessel Prosthesis Implantation Cardiovascular Cardiovascular Agents - therapeutic use Clinical trials Coronary Artery Disease - complications Coronary Artery Disease - therapy Coronary Restenosis - etiology Coronary Restenosis - prevention & control Databases, Factual Diabetes Diabetes Complications - therapy Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 - complications Drug therapy Follow-Up Studies Humans Meta-analysis Paclitaxel - therapeutic use Prosthesis Design Randomized Controlled Trials as Topic Risk factors Sirolimus - therapeutic use Stents Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!